CHARM Therapeutics Limited
Near the end of 2020, Deepmind announced that they had solved of the protein folding problem, a "50-year-old grand challenge in biology". Their approach was end-to-end deep learning, and it was the first time deep learning had solved an important scientific problem.
We believe this along with other recent breakthroughs in deep learning on 3D molecular configurations are the start of a new era in drug discovery, akin to the what AlexNet did for computer vision in 2012. Inspired by these breakthroughs, **CHARM Therapeutics** was founded with the mission to harness the power of deep learning to deliver medicines of transformational efficacy for patients.
We believe this along with other recent breakthroughs in deep learning on 3D molecular configurations are the start of a new era in drug discovery, akin to the what AlexNet did for computer vision in 2012. Inspired by these breakthroughs, **CHARM Therapeutics** was founded with the mission to harness the power of deep learning to deliver medicines of transformational efficacy for patients.